Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder (B-ACE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00873509|
Recruitment Status : Completed
First Posted : April 1, 2009
Last Update Posted : July 26, 2016
Chugani, Diane C.
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Diane C Chugani, Wayne State University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||January 2015|
|Actual Study Completion Date :||January 2015|
Publications of Results:
Chugani DC, Chugani HT, Wiznitzer M, Parikh S, Evans PA, Hansen RL, Nass R, Janisse JJ, Dixon-Thomas P, Behen M, Rothermel R, Parker JS, Kumar A, Muzik O, Edwards DJ, Hirtz D; Autism Center of Excellence Network. Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial. J Pediatr. 2016 Mar;170:45-53.e1-4. doi: 10.1016/j.jpeds.2015.11.033. Epub 2015 Dec 30.